PubRank
Search
About
Santi Barbera
Author PubWeight™ 16.74
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
J Natl Cancer Inst
2003
3.41
2
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
Lancet Oncol
2005
2.36
3
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
J Clin Oncol
2005
2.11
4
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol
2003
2.09
5
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
Lancet Oncol
2007
1.60
6
Supportive care in patients with advanced non-small-cell lung cancer.
Br J Cancer
2003
1.04
7
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
Lung Cancer
2013
0.90
8
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Lung Cancer
2012
0.83
9
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study.
Lung Cancer
2011
0.82
10
The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.
Lung Cancer
2008
0.76
11
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
J Thorac Oncol
2012
0.76
12
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.
Cancer
2005
0.75